Δημοσιεύσεις

265.  Nikolaos K. Gatselis , Vasiliki Lygoura, Aggeliki Lyberopoulou, George Giannoulis, Anna Samakidou, Antonia Vaiou, George Vatidis, Katerina Antoniou, Aggelos Stefos , Sarah Georgiadou, Dimitrios Sagris, Dafni Sveroni, Despoina Stergioula, Stella Gabeta , George Ntaios and George N. Dalekos. Soluble IL-2R Levels at Baseline Predict the Development of Severe Respiratory Failure and Mortality in COVID-19 Patients Stroke. Viruses 2022, 14(4), 787; (pdf)

264.  Ntaios G, Papavasileiou V, Sagris D, Makaritsis K, Vemmos K, Steiner T, Michel P. Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis. Stroke. 2018 Feb;49(2):412-418. doi: 10.1161/STROKEAHA.117.020030.

263. Papatheodoridis GV, Sypsa V, Dalekos G, Yurdaydin C, Van Boemmel F, Buti M, Goulis J, Luis Calleja J, Chi H, Manolakopoulos S, Loglio A, Siakavellas S, Gatselis N, Keskın O, Lehretz M, Savvidou S, de la Revilla J, Hansen BE, Kourikou A, Vlachogiannakos I, Galanis K, Idilman R, Colombo M, Esteban R, Janssen HLA, Berg T, Lampertico P. 8-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population. J Hepatol. 2018 Feb 7. pii: S0168-8278(18)30081-3. doi: 10.1016/j.jhep.2018.01.031.

262. Papanagiotou P, Ntaios G. Endovascular Thrombectomy in Acute Ischemic Stroke. Circ Cardiovasc Interv. 2018 Jan;11(1):e005362. doi: 10.1161/CIRCINTERVENTIONS.117.005362

261. Ntaios G, Hart RG. Embolic Stroke. Circulation 2017; 136:2403-5 (pdf)

260. Paciaroni M, Agnelli G, Falocci N, Tsivgoulis G, Vadikolias K, Liantinioti C, Chondrogianni M, Bovi P, Carletti M, Cappellari M, Zedde M, Ntaios G, Karagkiozi E, Athanasakis G, Makaritsis K, Silvestrelli G, Lanari A, Ciccone A, Putaala J, Tomppo L, Tatlisumak T, Abdul-Rahim AH, Lees KR, Alberti A, Venti M, Acciarresi M, D’Amore C, Becattini C, Mosconi MG, Cimini LA, Soloperto R, Masotti L, Vannucchi V, Lorenzini G, Tassi R, Guideri F, Acampa M, Martini G, Sohn SI, Marcheselli S, Mumoli N, De Lodovici ML, Bono G, Furie KL, Tadi P, Yaghi S, Toni D, Letteri F, Tassinari T, Kargiotis O, Lotti EM, Flomin Y, Mancuso M, Maccarrone M, Giannini N, Bandini F, Pezzini A, Poli L, Padovani A, Scoditti U, Denti L, Consoli D, Galati F, Sacco S, Carolei A, Tiseo C, Gourbali V, Orlandi G, Giuntini M, Chiti A, Giorli E, Gialdini G, Corea F, Ageno W, Bellesini M, Colombo G, Monaco S, Maimone Baronello M, Karapanayiotides T, Caso V. Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non-Vitamin-K Oral Anticoagulants (RAF-NOACs) Study. J Am Heart Assoc. 2017 Nov 29;6(12). doi: 10.1161/JAHA.117.007034.

259. Papanagiotou P, Ntaios G, Papavasileiou V, Psychogios K, Psychogios M, Mpotsaris A, Rizos T, Spengos K, Gravanis M, Vassilopoulou S, Gkogkas C, Zampakis P, Zis P, Karantanas A, Karygiannis M, Karydas G, Korompoki E, Makaritsis K, Marmagkiolis K, Milionis H, Mitsikostas D, Nikas D, Plomaritoglou A, Politi M, Ptochis N, Savopoulos C, Takis K, Tsamopoulos N, Tsetis D, Hatzidakis A, Chatziioannou A, Hatzitolios A, Vemmos K. Recommendations for Mechanical Thrombectomy in Patients with Acute Ischemic Stroke : A Clinical Guide by the Hellenic Stroke Organization. Clin Neuroradiol. 2017 Nov 17. doi: 10.1007/s00062-017-0645-1

 

258.  Harms MH, Lammers WJ, Thorburn D, Corpechot C, Invernizzi P, Janssen HLA, Battezzati PM, Nevens F, Lindor KD, Floreani A, Ponsioen CY, Mayo MJ, Dalekos GN, Bruns T, Parés A, Mason AL, Verhelst X, Kowdley KV, Goet JC, Hirschfield GM, Hansen BE, van Buuren HR. Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome. Am J Gastroenterol. 2017 Dec 12. doi: 10.1038/ajg.2017.440.

 

 

257.  Murillo Perez F, Goet JC, Lammers WJ, Gulamhusein A, van Buuren HR, Ponsioen CY, Carbone M, Mason A, Corpechot C, Invernizzi P, Mayo MJ, Battezzati PM, Floreani A, Pares A, Nevens F, Kowdley KV, Bruns T, Dalekos GN, Thorburn D, Hirschfield G, LaRusso NF, Lindor KD, Zachou K, Poupon R, Trivedi PJ, Verhelst X, Janssen HLA, Hansen BE; GLOBAL PBC Study Group. Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history. Hepatology. 2017 Dec 8. doi: 10.1002/hep.29717.

 

256. Sacco S, Merki-Feld G, Ægidius KL, Bitzer J, Canonico M, Kurth T, Lampl C, Lidegaard Ø, Anne MacGregor E, MaassenVanDenBrink A, Mitsikostas DD, Nappi RE, Ntaios G, Sandset PM, Martelletti P; European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain. 2017 Oct 30;18(1):108. doi: 10.1186/s10194-017-0815-1.

 

255. Papatheodoridis GV, Idilman R, Dalekos GN, Buti M, Chi H, van Boemmel F, Calleja JL, Sypsa V, Goulis J, Manolakopoulos S, Loglio A, Siakavellas S, Keskın O, Gatselis N, Hansen BE, Lehretz M, de la Revilla J, Savvidou S, Kourikou A, Vlachogiannakos I, Galanis K, Yurdaydin C, Berg T, Colombo M(, Esteban R, Janssen HLA, Lampertico P. The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B. Hepatology. 2017 Nov;66(5):1444-1453. doi: 10.1002/hep.29320. Epub 2017 Oct 11.

 

254. Skoutelis A, Pefanis A, Tsiodras S, Sipsas NV, Lelekis M, Lazanas MC, Gargalianos P, Dalekos GN, Roilides E, Samonis G, Maltezos E, Hatzigeorgiou D, Lada M, Metallidis S, Stoupis A, Chrysos G, Karnesis L, Symbardi S, Loupa CV, Giamarellou H, Kioumis I, Sambatakou H, Tsianos E, Kotsopoulou M, Georgopali A, Liakou K, Perlorentzou S, Levidiotou S, Giotsa-Toutouza M, Tsorlini-Christoforidou H, Karaiskos I, Kouppari G, Trikka-Graphakos E, Ntrivala MA, Themeli-Digalaki K, Pangalis A, Kachrimanidou M, Martsoukou M, Karapsias S, Panopoulou M, Maraki S, Orfanou A, Petinaki E, Orfanidou M Baka V, Stylianakis A, Spiliopoulou I, Smilakou S, Zerva L, Vogiatzakis E, Belesiotou E, Gogos CA. Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study. 1. PLoS One. 2017 Aug 16;12(8):e0182799. doi: 10.1371/journal.pone.0182799

 

253. Woodhouse LJ, Scutt P, Hamdy S, Smithard DG, Cohen DL, Roffe C, Bereczki D, Berge E, Bladin CF, Caso V, Christensen HK, Collins R, Czlonkowska A, de Silva A, Etribi A, Laska AC, Ntaios G, Ozturk S, Phillips SJ, Prasad K, Szatmari S, Sprigg N, Bath PM. Route of Feeding as a Proxy for Dysphagia After Stroke and the Effect of Transdermal Glyceryl Trinitrate: Data from the Efficacy of Nitric Oxide in Stroke Randomised Controlled Trial. Transl Stroke Res. 2017 Aug 2. doi: 10.1007/s12975-017-0548-0. [Epub ahead of print] PubMed PMID: 28770403.

 

 

252. Wranke A, Pinheiro Borzacov LM, Parana R, Lobato C, Hamid S, Ceausu E, Dalekos N, Rizzetto M, Turcanu A, Niro GA, Lubna F, Abbas M, Ingiliz P, Buti M, Ferenci  P, Vanwolleghem T, Hayden T, Dashdorj N, Motoc A, Cornberg M, Abbas Z, Yurdaydin C, Manns MP, Wedemeyer H, Hardtke S; Hepatitis Delta International Network. Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN). Liver Int. 2017 Sep 29. doi: 10.1111/liv.13604. [Epub ahead of print] PubMed PMID: 28963781.

 

 

251. Milionis H, Ntaios G, Papavasileiou V, Spengos K, Manios E, Elisaf M, Vemmos K. Aspirin Versus Clopidogrel for Type 2 Diabetic Patients with First-Ever Noncardioembolic Acute Ischemic Stroke: Ten-Year Survival Data from the Athens Stroke Outcome Project. J Stroke Cerebrovasc Dis. 2017 Jul 27. pii: S1052-3057(17)30348-8. doi: 10.1016/j.jstrokecerebrovasdis.2017.06.052. [Epub ahead of print] PubMed PMID: 28756905.

 

 

250. Polychronopoulou E, Lygoura V, Gatselis NK, Dalekos GN. Increased cholestatic enzymes in two patients with long-term history of ulcerative colitis: consider primary biliary cholangitis not always primary sclerosing cholangitis. BMJ Case Rep. 2017 Sep 25;2017. pii: bcr-2017-220824. doi: 10.1136/bcr-2017-220824. PubMed PMID: 28951510.

 

 

249. Learoyd AE, Woodhouse L, Shaw L, Sprigg N, Bereczki D, Berge E, Caso V, Christensen H, Collins R, Czlonkowska A, El Etribi A, Farr TD, Gommans J, Laska AC, Ntaios G, Ozturk S, Pocock SJ, Prasad K, Wardlaw JM, Fone KC, Bath PM, Trueman RC; ENOS Trial investigators. Infections Up to 76 Days After Stroke Increase Disability and Death. Transl Stroke Res. 2017 Jul 27. doi: 10.1007/s12975-017-0553-3. [Epub ahead of print] PubMed PMID: 28752410.

 

 

248. Papatheodoridi Μ, Dalekos GN, Goulis J, Manolakopoulos S, Triantos C, Zachou K, Koukoufiki A, Κourikou Α, Ζisimopoulos Κ, Τsoulas C, Papatheodoridis GV. Prioritization for interferon-free regimens and potential drug interactions of current direct-acting anti-hepatitis C agents in routine clinical practice. Ann Gastroenterol. 2017;30(5):542-549. doi: 10.20524/aog.2017.0170. Epub 2017 Jun 26. PubMed PMID: 28845110; PubMed Central PMCID: PMC5566775.

 

247. Ntaios G, Papavasileiou V, Diener HC, Makaritsis K, Michel P. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated  systematic review and meta-analysis of randomized controlled trials. Int J Stroke. 2017 Aug;12(6):589-596. doi: 10.1177/1747493017700663. Epub 2017 Mar 15.  PubMed PMID: 28730948.

 

246. Skoutelis A, Pefanis A, Tsiodras S, Sipsas NV, Lelekis M, Lazanas MC, Gargalianos P, Dalekos GN, Roilides E, Samonis G, Maltezos E, Hatzigeorgiou D, Lada M, Metallidis S, Stoupis A, Chrysos G, Karnesis L, Symbardi S, Loupa CV, Giamarellou H, Kioumis I, Sambatakou H, Tsianos E, Kotsopoulou M, Georgopali A, Liakou K, Perlorentzou S, Levidiotou S, Giotsa-Toutouza M, Tsorlini-Christoforidou H, Karaiskos I, Kouppari G, Trikka-Graphakos E, Ntrivala MA, Themeli-Digalaki K, Pangalis A, Kachrimanidou M, Martsoukou M, Karapsias S, Panopoulou M, Maraki S, Orfanou A, Petinaki E, Orfanidou M, Baka V, Stylianakis A, Spiliopoulou I, Smilakou S, Zerva L, Vogiatzakis E, Belesiotou E, Gogos CA. Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study. PLoS One. 2017 Aug 16;12(8):e0182799. doi:10.1371/journal.pone.0182799. eCollection 2017. PubMed PMID: 28813492; PubMed Central PMCID: PMC5559069.

 

 

245. Ntaios G, Papavasileiou V, Makaritsis K, Vemmos K, Michel P, Lip GYH. Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis. Stroke. 2017 Sep;48(9):2494-2503. doi: 10.1161/STROKEAHA.117.017549. Epub 2017 Jul 17. Review. PubMed PMID: 28716982.

 

 

244.Alberts R, de Vries EMG, Goode EC, Jiang X, Sampaziotis F, Rombouts K, Böttcher K, Folseraas T, Weismüller TJ, Mason AL, Wang W, Alexander G, Alvaro D,  Bergquist A, Björkström NK, Beuers U, Björnsson E, Boberg KM, Bowlus CL, Bragazzi MC, Carbone M, Chazouillères O, Cheung A, Dalekos G, Eaton J, Eksteen B, Ellinghaus D, Färkkilä M, Festen EAM, Floreani A, Franceschet I, Gotthardt DN, Hirschfield GM, Hoek BV, Holm K, Hohenester S, Hov JR, Imhann F, Invernizzi P, Juran BD, Lenzen H, Lieb W, Liu JZ, Marschall HU, Marzioni M, Melum E, Milkiewicz P, Müller T, Pares A, Rupp C, Rust C, Sandford RN, Schramm C, Schreiber S, Schrumpf E, Silverberg MS, Srivastava B, Sterneck M, Teufel A, Vallier L, Verheij J, Vila AV, Vries B, Zachou K; International PSC Study Group, The UK PSC Consortium,  hapman RW, Manns MP, Pinzani M, Rushbrook SM, Lazaridis KN, Franke A, Anderson CA, Karlsen TH, Ponsioen CY, Weersma RK. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis. Gut. 2017 Aug 4. pii: gutjnl-2016-313598. doi: 10.1136/gutjnl-2016-313598. [Epub ahead of print] PubMed PMID: 28779025.

 

 

243. Ntaios G, Lip GYH, Vemmos K, Koroboki E, Manios E, Vemmou A, Rodríguez-Campello A, Cuadrado-Godia E, Roquer J, Arnao V, Caso V, Paciaroni M, Diez-Tejedor E, Fuentes B, Pérez Lucas J, Arauz A, Ameriso SF, Pertierra L, Gómez-Schneider M, Hawkes MA, Bandini F, Chavarria Cano B, Iglesias Mohedano AM, García Pastor A, Gil-Núñez A, Putaala J, Tatlisumak T, Barboza MA, Athanasakis G, Gioulekas F, Makaritsis K, Papavasileiou V. Age- and sex-specific analysis of patients with embolic stroke of undetermined source. Neurology. 2017 Aug 8;89(6):532-539. doi: 10.1212/WNL.0000000000004199. Epub 2017 Jul 7. PubMed PMID: 28687720; PubMed Central PMCID: PMC5562957.

 

 

242. Papatheodoridis GV, Idilman R, Dalekos GN, Buti M, Chi H, van Boemmel F, Calleja JL, Sypsa V, Goulis J, Manolakopoulos S, Loglio A, Siakavelas S, Keskın O, Gatselis N, Hansen BE, Lehretz M, de la Revilla J, Savvidou S, Kourikou A, Vlachogiannakos I, Galanis K, Yurdaydin C, Berg T, Colombo M, Esteban R, Janssen  HLA, Lampertico P. The risk of hepatocellular carcinoma is decreasing after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B. Hepatology. 2017 Jun 16. doi: 10.1002/hep.29320. [Epub ahead of print] PubMed PMID: 28622419.

 

 

241. Gatselis NK, Zachou K, Lygoura V, Azariadis K, Arvaniti P, Spyrou E, Papadamou G, Koukoulis GK, Dalekos GN, Rigopoulou EI. Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece. Eur J Intern Med. 2017 May 20. pii: S0953-6205(17)30182-6.  (pubmed)

 

240. Sinakos E, Kountouras D, Koskinas J, Zachou K, Karatapanis S, Triantos C, Vassiliadis T, Goulis I, Kourakli A, Vlachaki E, Toli B, Tampaki M, Arvaniti P, Tsiaoussis G, Bellou A, Kattamis A, Maragkos K, Petropoulou F, Dalekos GN, Akriviadis E, Papatheodoridis GV. Treatment of chronic hepatitis C with direct-acting antivirals in patients with b-thalassemis major and advanced liver disease. Br J Haematology 2017, April 25th (pubmed)

 

239. Zachou K, Gabeta S, Gatselis NK, Norman GL, Dalekos GN. Cartilage oligometric matrix protein on the spot for liver fibrosis evaluation: too early or too late? Eur J Intern Med 2017; May 11th (pubmed)

 

238. Rigopoulou EI, Ioannou M, Papadamou G, Dalekos GN. Ascites in a patient with episodic angio-edema and eosinophilia: thinking outside the box. BMJ Case Rep. 2017 Apr 21;2017 (pubmed).

 

237. Hart RG, Catanese L, Perera KS, Ntaios G, Connolly SJ. Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update. Stroke. 2017 Apr;48(4):867-872. ( pubmed)

 

236. Weismüller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, Holm K, Gotthardt D, Färkkilä MA, Marschall HU, Thorburn D, Weersma RK, Fevery J, Mueller T, Chaouillères O, Schulze K, Lazaridis KN, Almer S, Pereira SP, Levy C, Mason A, Naess S, Bowlus CL, Floreani A, Halilbasic E, Yimam KK, Milkiewicz P, Beuers U, Huynh DK, Pares A, Manser CN, Dalekos GN, Eksteen B, Invernizzi P, Berg CP, Kirchner GI, Sarrazin C, Zimmer V, Fabris L, Braun F, Marzioni M, Juran BD, Said K, Rupp C, Jokelainen K, Benito de Valle M, Saffioti F, Cheung A, Trauner M, Schramm C, Chapman RW, Karlsen TH, Schrumpf E, Strassburg CP, Manns MP, Lindor KD, Hirschfield GM, Hansen BE, Boberg KM; International PSC Study Group. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis. Gastroenterology. 2017 Mar 5. pii: S0016-5085(17)30236-6 (pubmed)

 

235. Gatselis NK, Vakrakou AG, Zachou K, Androutsakos T, Azariadis K, Hatzis G, Manoussakis MN, Dalekos GN. Decreased serum DNase1-activity in patients with autoimmune liver diseases. Autoimmunity. 2017 Mar;50(2):125-132 (pubmed)

 

234. Zachou K, Arvaniti P, Gatselis NK, Azariadis K, Papadamou G, Rigopoulou E, Dalekos GN. Patients with Haemoglobinopathies and Chronic Hepatitis C: A Real Difficult to Treat Population in 2016? Mediterr J Hematol Infect Dis. 2017 Jan 1;9(1):e2017003 (pubmed)

 

233. Paciaroni M, Agnelli G, Caso V, Tsivgoulis G, Furie KL, Tadi P, Becattini C, Falocci N, Zedde M, Abdul-Rahim AH, Lees KR, Alberti A, Venti M, Acciarresi M, D’Amore C, Mosconi MG, Cimini LA, Procopio A, Bovi P, Carletti M, Rigatelli A, Cappellari M, Putaala J, Tomppo L, Tatlisumak T, Bandini F, Marcheselli S, Pezzini A, Poli L, Padovani A, Masotti L, Vannucchi V, Sohn SI, Lorenzini G, Tassi R, Guideri F, Acampa M, Martini G, Ntaios G, Karagkiozi E, Athanasakis G, Makaritsis K, Vadikolias K, Liantinioti C, Chondrogianni M, Mumoli N, Consoli D, Galati F, Sacco S, Carolei A, Tiseo C, Corea F, Ageno W, Bellesini M, Colombo G, Silvestrelli G, Ciccone A, Scoditti U, Denti L, Mancuso M, Maccarrone M, Orlandi G, Giannini N, Gialdini G, Tassinari T, De Lodovici ML, Bono G, Rueckert C, Baldi A, D’Anna S, Toni D, Letteri F, Giuntini M, Lotti EM, Flomin Y, Pieroni A, Kargiotis O, Karapanayiotides T, Monaco S, Baronello MM, Csiba L, Szabó L, Chiti A, Giorli E, Del Sette M, Imberti D, Zabzuni D, Doronin B, Volodina V, Michel P, Vanacker P, Barlinn K, Pallesen LP, Kepplinger J, Bodechtel U, Gerber J, Deleu D, Melikyan G, Ibrahim F, Akhtar N, Gourbali V, Yaghi S. Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study. Stroke. 2017 Mar;48(3):726-732 (pubmed)

 

232. Zachou K, Gabeta S, Shums Z, Gatselis NK, Koukoulis GK, Norman GL, Dalekos GN. COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis. Eur J Intern Med. 2017 Jan 15. pii: S0953-6205(17)30027-4. (pubmed)

 

 

231. Zachou K, Arvaniti P, Gatselis NK, Azariadis K, Papadamou G, Rigopoulou E, Dalekos GN. Patients with Haemoglobinopathies and Chronic Hepatitis C: A Real Difficult to Treat Population in 2016? Mediterr J Hematol Infect Dis. 2017 Jan 1;9(1):e2017003 (pubmed)

 

230. Laskari K, Boura P, Dalekos GN, Garyfallos A, Karokis D, Pikazis D, Settas L, Skarantavos G, Tsitsami E, Sfikakis PP. Longterm Beneficial Effect of Canakinumab in Colchicine-resistant Familial Mediterranean Fever. J Rheumatol. 2017 Jan;44(1):102-109 (pubmed)

 

229. Giamarellos-Bourboulis EJ, Tsaganos T, Tsangaris I, Lada M, Routsi C, Sinapidis D, Koupetori M, Bristianou M, Adamis G, Mandragos K, Dalekos GN, Kritselis I, Giannikopoulos G, Koutelidakis I, Pavlaki M, Antoniadou E, Vlachogiannis G, Koulouras V, Prekates A, Dimopoulos G, Koutsoukou A, Pnevmatikos I, Ioakeimidou A, Kotanidou A, Orfanos SE, Armaganidis A, Gogos C; Hellenic Sepsis Study Group. Validation of the new sepsis-3 definition: proposal for improvement in early risk identification. Clin Microbiol Infect 2016 (pubmed)

 

228. Liberal R, de Boer YS, Andrade RJ, Bouma G, Dalekos GN, Floreani A, Gleeson D, Hirschfield GM, Invernizzi P, Lenzi M, Lohse AW, Macedo G, Milkiewicz P, Terziroli B, van Hoek B, Vierling JM, Heneghan MA; International Autoimmune Hepatitis Group (IAIHG). Expert clinical management of autoimmmune hepatitis in the real world. Aliment Pharmacol Ther. 2016 online early (pubmed)

 

227. Kaffe E, Katsifa A, Xylourgidis N, Ninou I, Zannikou M, Harokopos V, Foka P, Dimitriadis A, Evangelou K, Moulas AN, Georgopoulou U, Gorgoulis VG, Dalekos GN, Aidinis V. Hepatocyte autotaxin expression promotes liver fibrosis and cancer. Hepatology 2016, online early (pubmed)

 

226. Diener HC, Bernstein R, Butcher K, Campbell B, Cloud G, Davalos A, Davis S, Ferro JM, Grond M, Krieger D, Ntaios G, Slowik A, Touzé E. Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion.International Journal of Stroke 2016, online early (pdf)

 

225. Gatselis NK, Skendros P, Ritis K, Dalekos GN. Severe liver involvement in two patients with long-term history of fever: remember familial Mediterranean fever. BMJ Case Rep. 2016 Sep 22;2016. pii: bcr2016216941. doi: 10.1136/bcr-2016-216941. (pubmed)

 

224. George Ntaios, Vasileios Papavasileiou, Gregory Y.H. Lip, Haralampos Milionis, Konstantinos Makaritsis, Anastasia Vemmou, Eleni Koroboki, Efstathios Manios, Konstantinos Spengos, Patrik Michel, Konstantinos Vemmos. Embolic Stroke of Undetermined Source and Detection of Atrial Fibrillation on Follow-Up: How Much Causality Is There? Journal of Stroke and Cerebrovascular Diseases 2016, online early (pdf)

 

223. Ntaios G, Vemmos K, Lip GY, Koroboki E, Manios E, Vemmou A, Rodríguez-Campello A, Cuadrado-Godia E, Giralt-Steinhauer E, Arnao V, Caso V, Paciaroni M, Diez-Tejedor E, Fuentes B, Pérez Lucas J, Arauz A, Ameriso SF, Hawkes MA, Pertierra L, Gómez-Schneider M, Bandini F, Chavarria Cano B, Iglesias Mohedano AM, García Pastor A, Gil-Núñez A, Putaala J, Tatlisumak T, Barboza MA, Athanasakis G, Makaritsis K, Papavasileiou V. Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source. Stroke 2016, online early (pdf)

 

222. Papatheodoridis G, Thomas HC, Golna C, Bernardi M, Carballo M, Cornberg M, Dalekos G, Degertekin B, Dourakis S, Flisiak R, Goldberg D, Gore C, Goulis I, Hadziyannis S, Kalamitsis G, Kanavos P, Kautz A, Koskinas I, Leite BR, Malliori M, Manolakopoulos S, Matičič M, Papaevangelou V, Pirona A, Prati D, Raptopoulou-Gigi M, Reic T, Robaeys G, Schatz E, Souliotis K, Tountas Y, Wiktor S, Wilson D, Yfantopoulos J, Hatzakis A. Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference. J Viral Hepat. 2016 Feb;23 Suppl 1:1-12. (pubmed)

 

 

221. Robert G Hart, Mukul Sharma, Hardi Mundl, Ashkan Shoamanesh, Scott E Kasner, Scott D Berkowitz, Guillaume Pare, Bodo Kirsch, Janice Pogue, Calin Pater, Gary Peters, Antoni Davalos, Wilfried Lang, Yongjun Wang, Yilong Wang, Luis Cunha, Jens Eckstein, Turgut Tatlisumak, Nikolay Shamalov, Robert Mikulik, Pablo Lavados, Graeme J Hankey, Anna Czlonkowska, Danilo Toni, Sebastian F Ameriso, Rubens J Gagliardi, Pierre Amarenco, Daniel Bereczki, Shinichiro Uchiyama, Arne Lindgren, Matthias Endres, Raf Brouns, Byung-Woo Yoon, George Ntaios, Roland Veltkamp, Keith W Muir, Serefnur Ozturk, Antonio Arauz, Natan Bornstein, Alan Bryer, Martin J O’Donnell, Jeffrey Weitz, Frank Peacock, Ellison Themeles and Stuart J Connolly. Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial. European Stroke Journal 2016, online early (pdf)

 

220. Gatselis N, Dalekos GN. Molecular diagnostic testing for primary biliary cholangitis. Expert Rev Mol Diagn 2016, online early (pubmed)

 

219. Ntaios G, Gioulekas F, Papavasileiou V, Strbian D, Michel P. ASTRAL, DRAGON and SEDAN scores predict stroke outcome more accurately than physicians. European Journal of Neurology 2016, in press (pdf)

 

218. Niro GA, Smedile A, Fontana R, Olivero A, Ciancio A, Valvano MR, Pittaluga F, Coppola N,Wedemeyer H, Zachou K, Marrone A, Fasano M, Lotti G, Andreone P, Iacobellis A, Andriulli A, Rizzetto M. HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response. Aliment Pharmacol Ther. 2016 online early (pubmed)

 

217. Milionis H, Barkas F, Ntaios G, Papavasileiou V, Vemmos K, Michel P, Elisaf M. Proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors to treat hypercholesterolemia: effect on stroke risk. Eur J Int Medicine 2016 pii: S0953-6205(16)30192-3 (pdf).

 

216. Ntaios G, Kent T. Insulin resistance intervention after stroke trial of pioglitazone: Is this perhaps the end of the beggining? Stroke 2016, online early (pdf)

 

215. Tziomalos K, Ntaios G, Miyakis S, Papanas N, Xanthis A, Agapakis D, Milionis H, Savopoulos C, Maltezos E, Hatzitolios A. Prophylactic antibiotic treatment in severe acute ischemic stroke: the antimicrobial chemoprophylaxis for ischemic stroke in Macedonia-Thrace Study (ARISTEIDIS). Intern Emerg Med 2016, online early (pdf)

 

214. G Ntaios, H Milionis, K Vemmos, K Makaritsis, J Ferrari , D Strbian , S Curtze , T Tatlisumak, P Michel and V Papavasileiou. Small-vessel occlusion versus large-artery atherosclerotic strokes in diabetics: Patient characteristics, outcomes, and predictors of stroke mechanism. European Stroke Journal 2016, online early (pdf)

 

213. G Dalekos, K. Zachou. Editorial: autoimmune hepatitis – identifying options for treatment. Authors’ reply. Aliment Pharmacol Ther 2016;43:1237-8 (pubmed)

 

212. Achimastos A, Alexandrides T, Alexopoulos D, Athyros V, Bargiota A, Bilianou E, Chrysochoou C, Drogari E, Elisaf M, Ganotakis E, Goudevenos I, Ioannidis I, Kolovou G, Kotsis V, Lekakis I, Liberopoulos E, Melidonis A, Nikolaou V, Ntaios G, Papanas N, Pappas S, Pitsavos C, Rallidis L, Richter D, Skoumas I, Tentolouris N, Tousoulis D, Tselepis A, Tsioufis K, Tziakas D, Tziomalos K, Vardas P, Vlachopoulos C, Vlahakos D. Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. Hormones (Athens). 2016 Jan;15(1):8-14 (pdf)

 

211. Zachou K, Gatselis N, Arvaniti P, Gabeta S, Rigopoulou EI, Koukoulis GK, Dalekos GN. A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis. Aliment Pharmacol Therapy 2016, online early (pubmed)

 

210. Vanacker P, Heldner M, Amiguet M, Faouzi M, Cras P, Ntaios G, Arnold M, Mattle H, Gralla J, Fischer U, Michel P. Prediction of large vessel occlusion in acute stroke: National Institute of Health Stroke Scale is hard to beat. Critical Care Medicine 2016, online early (pdf)

 

209. Lohse AW, Chazouilleres O, Dalekos G, Drenth J, Heneghan M, Hofer H, Lammert F, Lenzi M. Clinical Practice Guidelines Autoimmune hepatitis: further considerations. J Hepatol 2016; pii:S0168-8278(16)00159-8 (pdf)

 

208. Kailash Krishnan, Polly Scutt, Lisa Woodhouse, Alessandro Adami, Jennifer L. Becker, Lesley A. Cala, Ana M. Casado, Christopher Chen, Robert A. Dineen, John Gommans, Panos Koumellis, Hanna Christensen, Ronan Collins, Anna Czlonkowska, Kennedy R. Lees, George Ntaios, Serefnur Ozturk, Stephen J. Phillips, Nikola Sprigg, Szabolcs Szatmari, Joanna M. Wardlaw, Philip M. Bath, DSc, FRCP* for the ENOS Investigators. Continuing versus Stopping Prestroke Antihypertensive Therapy in Acute Intracerebral Hemorrhage: A Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke Trial. Journal of Stroke and Cerebrovascular Diseases 2016, online early (pdf)

 

207. Georgitsi MD, Vitoros V, Panou C, Tsangaris I, Aimoniotou E, Gatselis NK, Chasou E, Kouliatsis G, Leventogiannis K, Velissaris D, Belesiotou E , Dioritou-Aggaliadou O, Giannitsioti E, Netea MG, Giamarellos-Bourboulis EJ, Giannikopoulos G, Alexiou Z, Voloudakis N, Koutsoukou A; Hellenic Sepsis Study Group. Individualized significance of the -251 A/T single nucleotide polymorphism of interleukin-8 in severe infections. Eur J Clin Microbiol Infect Dis. 2016 online early (pubmed)

 

206. Papatheodoridis G, Dalekos G, Sypsa V, Yurdaydin C, Buti M, Goulis J, Calleja JL, Chi H, Manolakopoulos S, Mangia G, Gatselis N, Keskin O, Savvidou S, de la Revilla J, Hansen BE, Vlachogiannakos I, Galanis K, Idilman R, Colombo M, Esteban R, Janssen HL, Lampertico P. Page-B: Risk Score for Hepatocellular Carcinoma in Caucasians with Chronic Hepatitis B Under 5-Year Entecavir or Tenofovir Therapy. J Hepatol. 2015, online early (pubmed)

 

205. Oikonomou O, Sarrou S, Papagiannitsis CC, Georgiadou S, Mantzarlis K, Zakynthinos E, Dalekos GN, Petinaki E. Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data. BMC Infect Dis. 2015 Dec 9;15(1):559 (pubmed)

 

204. Krishnan K, Scutt P, Woodhouse L, Adami A, Becker JL, Berge E, Cala LA, Casado AM, Caso V,Chen C, Christensen H, Collins R, Czlonkowska A, Dineen RA, Gommans J, Koumellis P, Lees KR,Ntaios G, Ozturk S, Phillips SJ, Pocock SJ, de Silva A, Sprigg N, Szatmari S, Wardlaw JM, Bath PM. Glyceryl Trinitrate for Acute Intracerebral Hemorrhage: Results From the Efficacy of Nitric Oxide in Stroke (ENOS) Trial, a Subgroup Analysis. Stroke 2016, online early (pdf)

 

203. Ntaios G, Lip GYH. Difficult situations in anticoagulation after stroke: between Scylla and Charybdis. Current Opinion in Neurology 2016, online early (pdf)

 

202. Β. Άθυρος, Θ. Αλεξανδρίδης, Δ. Αλεξόπουλος, Α. Αχείμαστος, Π. Βάρδας, Δ. Βλαχάκος, Χ. Βλαχόπουλος, Ε. Γανωτάκης, Ι. Γουδέβενος, Ευ. Δρογκάρη, Μ. Ελισάφ, Ι. Ιωαννίδης, Γ. Κολοβού, Β. Κώτσης, Ι. Λεκάκης, Ευ. Λυμπερόπουλος, Α. Μελιδώνης, Α. Μπαργιώτα, Ε. Μπιλιανού, Β. Νικολάου, Γ. Ντάιος, Ν. Παπάνας, Στ. Παππάς, Χ. Πίτσαβος, Λ. Ραλλίδης, Δ. Ρίχτερ, Ι. Σκούμας, Ν. Τεντολούρης, Δ. Τζιακάς, Κ. Τζιόμαλος, Δ. Τούσουλης, Α. Τσελέπης, Κ. Τσιούφης, Χ. Χρυσοχόου. Συμφωνία (Consensus) ειδικών για την ορθολογική χορήγηση των αναστολέων της PCSK9. Ελληνική Επιθεώρηση Αθηροσκλήρωσης 6(Συμπλήρωμα):3–8 (pdf)

 

201. Seaton RA, Menichetti F, Dalekos G, Beiras-Fernandez A, Nacinovich F, Pathan R, Hamed K. Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin® Outcomes Registry and Experience. Advances in Therapy 2015, online early (pubmed)

 

200. Γ. Ντάιος. Εμβολικά εγκεφαλικά απροσδιόριστης προέλευσης. Μια νέα κατηγορία ασθενών με ισχαιμικό εγκεφαλικό επεισόδιο. Heart Vessels Stroke 2015 (pdf)

 

199. Woodhouse L, Scutt P, Krishnan K, Berge E, Gommans J, Ntaios G, Wardlaw J, Sprigg N, Bath PM. Effect of Hyperacute Administration (Within 6 Hours) of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome After Stroke: Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial. Stroke 2015, online early (pdf)

 

198. Zachou K, Gampeta S, Gatselis NK, Oikonomou K, Goulis J, Manoussakis MN, Renaudineau Y, Bogdanos DP, Dalekos GN. Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis. Liver International 2015, online early (pdf)

 

197. Papavasileiou V, Milionis H, Smith CJ, Makaritsis K, Bray BD, Michel P, Manios E, Vemmos K, Ntaios G. External Validation of the Prestroke Independence, Sex, Age, National Institutes of Health Stroke Scale (ISAN) Score for Predicting Stroke-Associated Pneumonia in the Athens Stroke Registry. J Stroke Cerebrovasc Dis. 2015 online early (pdf)

 

196. S.P. Georgiadou, K.P.. Makaritsis, G.N. Dalekos. Leishmaniasis revisited: current aspects on epidemiology, diagnosis and treatment. Journal of Translational Internal Medicine 2015; 3:43-50 (pdf)

 

195. Kakaletsis N, Ntaios G, Milionis H, Haidich AB, Makaritsis K, Savopoulos C, Berge E, Hatzitolios AI. Prognostic value of 24-h ABPM in acute ischemic stroke for short-, medium-, and long-term outcome: a systematic review and meta-analysis. Int J Stroke 2015, online early (pdf)

 

194. Lyberopoulou A, Chachami G, Gatselis NK, Kyratzopoulou E, Saitis A, Gabeta S, Eliades P, Paraskeva E, Zachou K, Koukoulis GK, Mamalaki A, Dalekos GN, Simos G. Low Serum Hepcidin in Patients with Autoimmune Liver Diseases. PlosOne 2015; 10(8):e0135486 (pubmed)

 

193. Norman GL, Gatselis NK, Shums Z, Liaskos C, Bogdanos DP, Koukoulis GK, Dalekos GN. Cartilage oligomeric matrix protein: A novel non-invasive marker for assessing cirrhosis and risk of hepatocellular carcinoma. World J Hepatol. 2015; 7(14):1875-83 (pubmed)

 

192. Ntaios G, Papavasileiou V, Milionis H, Makaritsis K, Manios E, Spengos K, Michel P, Vemmos K. Embolic strokes of undetermined source in the Athens Stroke Registry: an outcome analysis. Stroke 2015, online early (pdf)

 

191. George Ntaios, Natan M. Bornstein, Valeria Caso, Hanne Christensen, Jacques De Keyser, Hans-Christoph Diener, Exuperio Diez-Tejedor, Jose M. Ferro, Gary A. Ford, Armin Grau, Emanuella Keller, Didier Leys, David Russell, Danilo Toni, Guillaume Turc, Bart Van der Worp, Nils Wahlgren, and Thorsten Steiner for the European Stroke Organisation. The European Stroke Organisation Guidelines: a standard operating procedure. International Journal of Stroke 2015, online early (pdf)

 

190. George Ntaios, Tomasz Dziedzic, Patrik Michel, Vasileios Papavasileiou, Jesper Petersson, Dimitre Staykov, Brenda Thomas, and Thorsten Steiner for the European Stroke Organisation. European Stroke Organisation (ESO) guidelines for the management of temperature in patients with acute ischemic stroke. International Journal of Stroke 2015, online early (pdf)

 

189. Kalafateli M, Kourakli A, Gatselis N, Lambropoulou P, Thomopoulos K, Tsamandas A, Christofidou M, Zachou K, Jelastopoulou E, Nikolopoulou V, Symeonidis A, Dalekos GN, Lambropoulou-Karatza C, Triantos C. Efficacy of Interferon A-2b monotherapy in Β-thalassemics with chronic hepatitis C. J Gastrointestin Liver Dis. 2015 Jun;24(2):189-96 (pubmed)

 

188. Keskin O, Wedemeyer H, Tüzün A, Zachou K, Deda X, Dalekos GN, Heidrich B, Pehlivan S, Zeuzem S, Yalçın K, Gürel S, Tabak F, Idilman R, Bozkaya H, Manns M, Yurdaydın C. Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome. Clin Gastroenterol Hepatol. 2015, online early (pubmed)

 

187. Vanacker P, Lambrou D, Eskandari A, Ntaios G, Cras P, Maeder P, Meuli R, Michel P. Improving the Prediction of Spontaneous and Post-thrombolytic Recanalization in Ischemic Stroke Patients. Journal of Stroke and Cerebrovascular Diseases 2015, online early (pdf)

 

186. Makaritsis K, Liaskos C, Papadamou G, Dalekos GN. Spontaneous bacterial peritonitis: an unusual manifestation of brucellosis in a previous healthy male patient. BMJ Case Rep. 2015 Apr 22;2015. pii: bcr2015209387. doi: 10.1136/bcr-2015-209387. (pubmed)

 

185. Sarrou S, Liakopoulos A, Chasioti M, Foka A, Fthenakis G, Billinis C, Spyrou V, Pantelidi K, Roussaki-Schulze A, Lachanas V, Makaritsis K, Skoulakis C, Daikos GL, Dalekos GN, Spiliopoulou I, Petinaki E. Dissemination of Methicillin-Susceptible CC398 Staphylococcus aureus Strains in a Rural Greek Area. Plos One. 2015;10(4):e0122761 (pubmed)

 

184. Georgiadou SP, Stefos A, Spanakos G, Skrimpas S, Makaritsis K, Sipsas NV, Dalekos GN. Current clinical, laboratory and treatment outcome characteristics of visceral leishmaniasis: results from a 7-year retrospective study in Greece. Int J Infect Dis 2015, online early (pubmed)

 

183. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial. Lancet 2015; 385:617-28 (pubmed)

 

182. George Ntaios, Simona Sacco. Resuming anticoagulation after brain hemorrhage while on warfarin treatment: INR at the time of bleeding should be taken into consideration-authors’ reply. Internal and Emergency Medicine 2015, online early (pdf)

 

 

181. Ntaios G, Lip GY, Lambrou D, Papavasileiou V, Manios E, Milionis H, Spengos K, Makaritsis K,Vemmos K. Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation. Neurology 2015, online early (pdf)

 

180. George Ntaios, Vasiliki Melikoki, George Perifanos, Kalliopi Perlepe,Fotios Gioulekas, Anastasia Karagiannaki, Ioanna Tsantzali, Chrysanthi Lazarou, Nikolaos Beradze, Evdoxia Poulianiti, Matina Poulikakou, Theofanis Palantzas, Stavrina Kaditi, Fay Perlepe, George Sidiropoulos, Kyriaki Papageorgiou, Vasileios Papavasileiou, Konstantinos Vemmos, Konstantinos Makaritsis, George N. Dalekos. Poor Stroke Risk Perception despite Moderate Public StrokeAwareness: Insight from a Cross-sectional National Surveyin Greece. Journal of Stroke and Cerebrovascular Diseases 2015; online early (pdf)

 

179. Ntaios G, Papavasileiou V, Michel P, Tatlisumak T, Strbian D. Predicting Functional Outcome and Symptomatic Intracranial Hemorrhage in Patients With Acute Ischemic Stroke: A Glimpse Into the Crystal Ball? Stroke 2015, online early (pdf)

 

178. Ntaios G, Vemmos K.  Response to Letter Regarding Article,“Embolic Stroke of Undetermined Source in the Athens Stroke Registry:A Descriptive Analysis”. Stroke 2015, online early (pdf)

 

177. Vanacker P, Heldner MR, Seiffge D, Mueller H, Eskandari A, Traenka C, Ntaios G, Mosimann PJ, Sztajzel R, Mendes Pereira V, Cras P, Engelter S, Lyrer P, Fischer U, Lambrou D, Arnold M, Michel P. ASTRAL-R score predicts non-recanalisation after intravenous thrombolysis in acute ischaemic stroke. Thromb Haemost 2015, online early (pubmed)

 

176. Gatselis N, Zachou K, Koukoulis G, Dalekos GN. Autoimmune hepatitis, one disease with many faces: etiopathogenetic clinico-laboratory and histological characteristics. World J Gastroenterol 2015; 21: 60-83 (pubmed)

 

175. Ntaios G. Restarting oral anticoagulants after intracerebral hemorrhage:pros. Internal and Emergency Medicine 2014, online early (pdf)

 

174. Milionis H, Papavasileiou V, Eskandari A, D’ Ambrogio-Remillard S, Ntaios G, Michel P. Anemia on admission predicts short- and long-term outcomes in patients with acute ischemic stroke. International Journal of Stroke 2014, online early (pdf)

 

173. Ntaios G, Papavasileiou V, Milionis H, Makaritsis K, Manios E, Spengos K, Michel P, Vemmos K. Embolic strokes of undetermined source in the Athens Stroke Registry: a descriptive analysis. Stroke 2014, online early (pdf)

 

172. Goulis I, Karatapanis S, Akriviadis E, Deutsch M, Dalekos GN, Raptopoulou-Gigi M, Mimidis K, Germanidis G, Drakoulis C, Triantos C, Zintzaras E, Bakalos G, Papatheodoridis G. On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients. Liver Int 2014; online early (pubmed)

 

171. T. Steiner, R.A. Salman, G. Ntaios. The European Stroke Organisation (ESO) Guidelines. International Journal of Stroke 2014; 9:838-9 (pubmed)

 

170. Papatheodoridis GV, Dalekos GN, Yurdaydin C, Buti M, Goulis J, Arends P, Sypsa V, Manolakopoulos S, Mangia G, Gatselis N, Keskın O, Savvidou S, Hansen BE, Papaioannou C, Galanis K, Idilman R, Colombo M, Esteban R, Janssen HL, Lampertico P. Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir. J Hepatol 2014; in press (pubmed)

 

169. Anagnostou O, Manolakopoulos S, Bakoyannis G, Papatheodoridis G, Zisouli A, Raptopoulou-Gigi M, Manesis E, Ketikoglou I, Dalekos G, Gogos C, Vassiliadis T, Tzourmakliotis D, Karatapanis S, Kanatakis S, Zoumpoulis -, Hounta A, Koutsounas S, Giannoulis G, Tassopoulos N, Touloumi G. Genotype 4 HCV infection is difficult to cure with pegylated interferon and ribavirin. Results from a Greek Nationwide Cohort Study. Hippokratia 2014;  18:57-64 (pubmed)

 

168. Kaffe ET, Rigopoulou EI, Koukoulis GK, Dalekos GN, Moulas AN. Oxidative stress and antioxidant status in patients with autoimmune liver disease. Redox Rep 2014, online early (pubmed)

 

167. Zachou K, Gampeta S, Gatselis N, Oikonomou K, Goulis J, Manoussakis M, Renaudineau Y, Bogdanos D, Dalekos GN. Anti-SLA/LP alone or in combination with anti-Ro52 antibodies in patients with autoimmune hepatitis. Liver International 2014, online early (pubmed)

 

166. Papatheodoridis GV, Manolakopoulos S, Touloumi G, Nikolopoulou G, Raptopoulou-Gigi M, Gogos C, Vafiadis-Zouboulis I, Karamanolis D, Chouta A, Ilias A, Drakoulis C, Mimidis K, Ketikoglou I, Manesis E, Mela M, Hatzis G, Dalekos GN; the HepNet.Greece Study Group. Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort. J Viral Hepat. 2014 Jul 15. doi: 10.1111/jvh.12283. [Epub ahead of print] (pubmed)

 

165. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the ‘Efficacy of Nitric Oxide in Stroke’ (ENOS) trial. International Journal of Stroke 2014, online early (pubmed)

 

 

163. Ntaios G, Papavasileiou V, Makaritsis K, Milionis H, Michel P, Vemmos K. Association of ischaemic stroke subtype with long-term cardiovascular events. European Journal of Neurology 2014, online early (pubmed)

 

162. Gatselis N, Zachou K, Saitis A, Samara M, Dalekos GN. Individualization of chronic hepatitis C treatment according to the host characteristics. World Journal of Gastroenterology 2014; 20:2839-53 (pubmed)

 

161. Vanacker P, Lambrou D, Eskandari A, Maeder P, Meuli R, Ntaios G, Michel P. Improving prediction of recanalization in acute large vessel occlusive stroke. J Thromb Haemost 2014; online early (pubmed)

 

160. Georgiadou SP, Velegraki A, Arabatzis M, Neonakis I, Chatzipanagiotou S, Dalekos GN, Petinaki E. Cluster of Fusarium Verticillioides bloodstream infection among immunocompetent patients in an internal medicine department after reconstruction works in Larissa, Central Greece. J Hosp Infect 2014; online early (pubmed)

 

159. Heidrich B, Yurdaydin C, Kabacam G, Ratsch B, Zachou K, Bremer B, Dalekos GN, et al; for the HIDIT-1 Study Group. Late HDV RNA relapse after peginterferon alfa-based therapy of chronic hepatitis Delta. Hepatology 2014, in press (pubmed)

 

158. Rigopoulou EI, Zachou K, Gatselis N, Koukoulis GK, Dalekos GN. Autoimmune hepatitis in patients with chronic HBV and HCV infections: patterns of clinical characteristics, disease progression and outcome. Annals of Hepatology 2014; 13:127-35 (pubmed)

 

157. Ntaios G, Papavasileiou V, Makaritsis K, Michel P. Intravenous insulin treatment in acute stroke: a systematic review and meta-analysis of randomized controlled trials. International Journal of Stroke 2013; online early (pubmed).

 

156. Kabaçam G, Wedemeyer H, Savaş B, Keskin O, Dalekos G, Tabak F, Idilman R, Erhardt A, Yalçın K, Bozdayi MA, Bozkaya H, Manns M, Dienes H, Yurdaydın C; the HIDIT-1 Study Group. Role of immunohistochemistry for hepatitis D and hepatitis B virus in hepatitis delta. Liver Int. 2013, Epub ahead of print (pubmed)

 

155. Mazioti A, Gatselis N, Rountas C, Filippiadis DK, Tepetes K, Koukoulis GK, Fezoulidis I, Dalekos GN. Safety and efficacy of transcatheter arterial chemoembolization in the real-life management of unresectable hepatocellular carcinoma. Hepat Mon 2013; 13:e7070 (pubmed)

 

154. Rigopoulou EI, Zachou K, Gatselis NK, Papadamou G, Koukoulis GK, Dalekos GN. Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcome. World Journal of Hepatology 2013; 5:577-83 (pubmed)

 

153. Giamarellos-Bourboulis EJ, Apostolidou E, Lada M, Perdios I, Gatselis NK, Tsangaris I, Georgitsi M, Bristianou M, Kanni T, Sereti K, Kyprianou MA, Kotanidou A, Armaganidis A. Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome. Crit Care 2013; 17:R247 (pubmed)

 

152.Ntaios G, Papavasileiou V, Makaritsis K, Michel P. PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis. International Journal of Cardiology 2013, online early (pubmed)

 

151. Zachou K, Sarantopoulos A, Gatselis NK, Vassiliadis T, Gabeta S, Stefos A, Saitis A, Boura P, Dalekos GN. Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: A hidden threat. World J Hepatol. 5:387-92, 2013. (pubmed)

 

150. Manesis EK, Vourli G, Dalekos G, Vasiliadis T, Manolaki N, Hounta A, Koutsounas S, Vafiadis I, Nikolopoulou G, Giannoulis G, Germanidis G, Papatheodoridis G, Touloumi G. Prevalence And Clinical Course Of Hepatitis Delta Infection In Greece: A 13-Year Prospective Study. J Hepatol. 2013 Jul 10. doi:pii: S0168-8278(13)00452-2. 10.1016/j.jhep.2013.07.005. (pubmed)

 

149. Ntaios G, Lambrou D, Cuendet D, Michel P. Early Major Worsening in Ischemic Stroke: Predictors and Outcome.Neurocrit Care. 2013 Jun 25. (pubmed)

 

148. Gatselis NK, Zachou K, Norman GL, Gabeta S, Papamichalis P, Koukoulis GK, Dalekos GN. Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease. Autoimmunity. 2013 Jun 19. (pubmed)

 

147. Milionis H, Vemmou A, Ntaios G, Makaritsis K, Koroboki E, Papavasileiou V, Savvari P, Spengos K, Elisaf M, Vemmos K. Ankle-brachial index long-term outcome after first-ever ischaemic stroke. Eur J Neurol. 2013 Jun 7. doi: 10.1111/ene.12208. (pubmed)

 

146. Liu G, Ntaios G, Zheng H, Wang Y, Michel P, Wang DZ, Fang J, Papavasileiou V, Liu L, Dong K, Wang C, Zhao X, Wang Y. External validation of the ASTRAL score to predict 3- and 12-month functional outcome in the China National Stroke Registry. Stroke. 44:1443-5, 2013. (pubmed)

 

145. Papavasileiou V, Milionis H, Michel P, Makaritsis K, Vemmou A, Koroboki E, Manios E, Vemmos K, Ntaios G. ASTRAL Score Predicts 5-Year Dependence and Mortality in Acute Ischemic Stroke. 2013, doi: 10.1161/​STROKEAHA.113.001047 (pdf)

 

144. Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weismüller TJ, Eksteen B, Invernizzi P, Hirschfield GM, Gotthardt DN, Pares A, Ellinghaus D, Shah T, Juran BD, Milkiewicz P, Rust C, Schramm C, Müller T, Srivastava B, Dalekos G, Nöthen MM, Herms S, Winkelmann J, Mitrovic M, Braun F, Ponsioen CY, Croucher PJ, Sterneck M, Teufel A, Mason AL, Saarela J, Leppa V, Dorfman R, Alvaro D, Floreani A, Onengut-Gumuscu S, Rich SS, Thompson WK, Schork AJ, Næss S, Thomsen I, Mayr G, König IR, Hveem K, Cleynen I, Gutierrez-Achury J, Ricaño-Ponce I, van Heel D, Björnsson E, Sandford RN, Durie PR, Melum E, Vatn MH, Silverberg MS, Duerr RH, Padyukov L, Brand S, Sans M, Annese V, Achkar JP, Boberg KM, Marschall HU, Chazouillères O, Bowlus CL, Wijmenga C, Schrumpf E, Vermeire S, Albrecht M; UK-PSCSC Consortium; International IBD Genetics Consortium, Rioux JD, Alexander G, Bergquist A, Cho J, Schreiber S, Manns MP, Färkkilä M, Dale AM, Chapman RW, Lazaridis KN; International PSC Study Group, Franke A, Anderson CA, Karlsen TH. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nature Genetics 45:670-675, 2013. (pubmed)

 

143. Saitis A, Gatselis N, Zachou K, Dalekos GN. Use of TNFα antagonists in refractory AIH: Revealing the unforeseen. J Hepatol 2013 Mar 22. pii: S0168-8278(13)00196-7. doi: 10.1016/j.jhep.2013.02.029. (pubmed)

 

142. Ntaios G, Lip GY, Makaritsis K, Papavasileiou V, Vemmou A, Koroboki E, Savvari P, Manios E, Milionis H, Vemmos K. CHADS2, CHA2DS2-VASc, and long-term stroke outcome in patients without atrial fibrillation. Neurology 2013 Feb 13. (pubmed)

 

141. Ntaios G, Gatselis NK, Makaritsis K, Dalekos GN. Adipokines as mediators of endothelial function and atherosclerosis. Atherosclerosis 2013, doi: 10.1016/j.atherosclerosis.2012.12.029 (pubmed)

 

140. Zellos A, Spoulou V, Roma-Giannikou E, Karentzou O, Dalekos GN, Theodoridou M. Autoimmune hepatitis type-2 and Epstein-Barr virus infection in a toddler: art of facts or an artifact? Ann Hepatol 12:147-51, 2013. (pubmed)

 

139. Gatselis NK, Ntaios G, Makaritsis K, Dalekos GN. Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease. Clin Exp Med 2013. (pubmed)

 

138. Ntaios G, Faouzi M, Ferrari J, Lang W, Vemmos K, Michel P. An integer-based score to predict functional outcome in acute ischemic stroke: the ASTRAL score. Neurology. 78:1916-22, 2012. (pubmed)

 

137. Heidrich B, Serrano BC, Idilman R, Kabaçam G, Bremer B, Raupach R, Önder FO, Deterding K, Zacher BJ, Taranta A, Bozkaya H, Zachou K, Tillmann HL, Bozdayi AM, Manns MP, Yurdaydın C, Wedemeyer H. HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome. Liver Int 32:1415-25, 2012. (pubmed)

 

136. Ntaios G, Papavasileiou V, Diener HC, Makaritsis K, Michel P. Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of randomized controlled trials.Stroke 43:3298-304, 2012. (pubmed)

 

135. Ntaios G, Lambrou D, Michel P. Blood pressure changes in acute ischemic stroke and outcome with respect to stroke etiology.Neurology 79:1440-8, 2012. (pubmed)

 

134. Saitis A, Gatselis NK, Dalekos GN. Leishmaniasis-associated haemophagocytic syndrome revisited: not an uncommon clinical presentation of leishmaniasis. J Med Cases 2012 (In press).

 

133. Mavroidi A, Miriagou V, Liakopoulos A, Tzelepi V, Stefos A, Dalekos GN, Petinaki E. Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification. BMS Infect Dis 12:371, 2012. (pubmed)

 

132. Skrimpas S, Polyzos A, Dalekos GN, Zachou K. Quiz: Sternoclavicular joint swelling in a previously healthy adult. Internal Med Open Access 2012 2:2.

 

131. Kabaçam G, Dalekos GN, Cakaloğlu Y, Zachou K, Bock T, Erhardt A, Zeuzem S, Tabak F, Yalçin K, Bozdayi AM, Dienes HP, Bozkaya H, Manns M, Wedemeyer H, Yurdaydin C. Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis. Turk J Gastroenterol 23:560-8, 2012. (pubmed)

 

130. Zografos TA, Gatselis N, Zachou K, Liaskos C, Gabeta S, Koukoulis GK, Dalekos GN. Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients. World J Gastroenterol 18:4721-8, 2012. (pubmed)

 

129. Stefos A, Gatselis N, Goudelas A, Mpakarosi M, Papaparaskevas J, Dalekos G, Petinaki E. Cutaneous infection caused by Bacillus anthracis in Larissa, Thessaly, Central Greece, July 2012. Euro Surveill 2012;17(32). pii: 20245. (pubmed)

 

128. Gatselis NK, Zachou K, Norman GL, Tzellas G, Speletas M, Gabeta S, Germenis A, Koukoulis GK, Dalekos GN. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases. Clin Chim Acta 413:1683-8, 2012. (pubmed)

 

127. Ntaios G, Vemmou A, Koroboki E, Savvari P, Makaritsis K, Saliaris M, Andrikopoulos G, Vemmos K. The type of atrial fibrillation is associated with long-term outcome in patients with acute ischemic stroke. Int J Cardiol, 2012 May 16. (pubmed)

 

126. Gatselis NK, Liamis G, Makaritsis KP, Dalekos GN. Metabolic Acidosis during Treatment of Mushroom Poisoning: A Diagnostic Pitfall.Intern Med 51:1077-80, 2012. (pubmed)

 

125. Mederacke I, Yurdaydin C, Großhennig A, Erhardt A, Cakaloglu Y, Yalcin K, Gurel S, Zeuzem S, Zachou K, Chatzikyrkou C, Bozkaya H, Dalekos GN, Manns MP, Wedemeyer H; on behalf of Hep-Net/International Delta Hepatitis Study Group. Renal function during treatment with adefovir plus peginterferon alfa-2a vs either drug alone in hepatitis B/D co-infection. J Viral Hepat 19:387-395, 2012.(pubmed)

 

124. Zachou K, Oikonomou K, Renaudineau Y, Chauveau A, Gatselis N, Youinou P, Dalekos GN. Anti-α actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1. Aliment Pharmacol Ther 35:116-25, 2012. (pubmed)

 

123. Mavroidi A, Miriagou V, Malli E, Stefos A, Dalekos GN, Tzouvelekis LS, Petinaki E. Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 β-lactamase. Int J Antimicrob Agents 39:247-50, 2012. (pubmed)

 

122. Tillmann HL, Zachou K, Dalekos GN. Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat? Liver Int 32:544-53, 2012. (pubmed)

 

121. Mederacke I, Yurdaydin C, Dalekos GN, Bremer B, Erhardt A, Cakaloglu Y, Yalcin K, Gurel S, Zeuzem S, Zachou K, Bozkaya H, Dienes HP, Manns MP, Wedemeyer H, Hep-Net/International Delta Hepatitis Study Group. Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment. Antivir Ther 17:305-312, 2012. (pubmed)

 

120. Papamichalis P, Alexiou A, Boulbou M, Dalekos GN, Rigopoulou EI. Reactivation of resolved hepatitis B virus infection after immunosuppression: Is it time to adopt pre-emptive therapy? Clin Res Hepatol Gastroenterol 36:84-93, 2012. (pubmed)

 

119. Argyraki CK, Gabeta S, Zachou K, Boulbou M, Polyzos A, Dalekos GN . Favourable outcome of life-threatening infectious-related haemophagocytic syndrome after combination treatment with corticosteroids and intravenous immunoglobulin infusions. Eur J Intern Med 22:155-157,2011. (pubmed)

 

118. Koumati E, Palassopoulou M, Matsouka P, Polyzos A, Dalekos GN, Zachou K.Multiple autoimmune propensity and B-non-hodgkin lymphoma: cause or effect? Autoimmune Dis 2011:841325, 2011. (pubmed)

 

117. Papamichalis P, Argyraki K, Papamichalis M, Loukopoulos A, Dalekos GN, Rigopoulou EI:Salmonella enteritidis Infection Complicated by Acute Myocarditis: A Case Report and Review of the Literature. Cardiol Res Pract  2011:574230, 2011. (pubmed)

 

116. Oikonomou KG, Zachou K, Dalekos GN. Alpha-actinin: A multidisciplinary protein with important role in B-cell driven autoimmunity.Autoimmun Rev 10:389-96, 2011. (pubmed)

 

115. Zachou K, Gatselis N, Papadamou G, Rigopoulou EI, Dalekos GN. Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients. J Hepatol  55:636-46, 2011. (pubmed)

 

114. Zachou K, Dalekos GN. Hepatitis B re-activation with rituximab therapy: treat the patient not the disease. Liver Int 31:277-279, 2011. (pubmed)

 

113. Wedemeyer H, Yurdaydın C, Dalekos GN, Erhardt A, Çakaloğlu Y, Değertekin H, Gürel S, Zeuzem S, Zachou K, Bozkaya H, Koch A, Bock T, Dienes HP, Manns MP. Peginterferon plus adefovir versus either drug alone for hepatitis delta. New Engl J Med 364:322-331,2011. (pubmed)

 

112. Gatselis NK, Makaritsis KP, Gabranis I, Stefos A, Karanikas K and Dalekos GN. Unusual cardiovascular complications of brucellosis: two case reports and review fo the literature. J Med Case Reports 5:22, 2011. (pubmed)

 

111. Gatselis NK and Dalekos GN. Education and Imaging. Hepatobiliary and Pancreatic: Primary hepatic lymphoma. J Gastroenterol Hepatol 26:210, 2011. (pubmed)

 

110. Liu H, Norman GL, Shums Z, Worman HJ, Krawitt EL, Bizzaro N, Vergani D, Bogdanos DP, Dalekos GN, Milkiewicz P, Czaja AJ, Heathcote JE, Hirschfield GM, Tan EM, Miyachi K, Bignotto M, Battezzati P-M, Lleo A, Leung PS, Podda M, Gershwin ME, Invernizzi P. PBC Screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun 35:436-42, 2010. (pubmed)

 

109. E.I. Rigopoulou, G.N. Dalekos. Can mathematical models be useful in clinical hepatology? Liver Int 30:637-638, 2010. (Editorial). (pubmed)

 

108. Gatselis NK, Zachou K, Dalekos GN. Early primary biliary cirrhosis: a new association with erythema nodosum of unknown origin.Gastroenterol Res Pract 2010;2010. pii: 121620. (pubmed)

 

107. Gatselis NK, Zachou K, Papamichalis P, Koukoulis GK, Gabeta S, Dalekos GN, Rigopoulou EI. Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: A new or a complementary diagnostic score? Dig Liver Dis 42:807-12,2010. (pubmed)

 

106. E.I. Rigopoulou, G.N. Dalekos. Can mathematical models be useful in clinical hepatology? Liver Int 30:637-638, 2010. (Editorial). (pubmed)

 

105. Liaskos C, Norman GL, Moulas A, Garagounis A, Goulis I, Rigopoulou EI, Dalekos GN. Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosis. Clin Chim Acta 411:411-5, 2010. (pubmed)

 

104. P. Mina, S.P. Georgiadou, C. Rizos, G.N. Dalekos, E.I. Rigopoulou. Prevalence of occult HBV infection in haemodialysis patients from central Greece. World J Gastroenterol 16:225-31, 2010. (pubmed)

 

103. K. Zachou, C. Yurdaydin, U. Drebber, G.N. Dalekos, A. Erhardt, Y Cakaloglu, H. Degertekin, S. Gurel, S. Zeuzem, H. Bozkaya, V. Schlaphoff, H.P. Dienes, C.T. Bock, M.P. Manns and H. Wedemeyer for HIDT-1 Study Group. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver Int 30:430-437, 2010. (pubmed)

 

102. E. Tsironi, N. Gatselis, M.G. Kotoula, K. Zachou, M. Pefkianaki, F. Zacharaki, D.Z. Chatzoulis and G.N. Dalekos. Ocular disorders as the prevailing manifestations of the antiphospholipid syndrome: three case reports. Cases J 2:159, 2009. (pubmed)

 

101. A. Koutsoumpas, M. Mytilinaiou, D. Polymeros, G.N. Dalekos, D.P. Bogdanos. Anti-Helicobacter pylori antibody responses specific for VacA do not trigger primary biliary cirrhosis-specific anti-mitochondrial antibodies. Eur J Gastroenterol Hepatol (letter) 21: 1220, 2009.(pubmed)

 

100. E. Kapsalaki, N. Gatselis, A. Stefos, K. Makaritsis, A. Vassiou, I. Fezoulidis, G.N. Dalekos. Spontaneous Spondylodiscitis: Presentation, risk factors, diagnosis, management and outcome Int J Infect Dis 13: 564-569, 2009. (pubmed)

 

099. KP Makaritsis, Ch Neocleous, N Gatselis, E Petinaki and GN Dalekos. An immunocompetent patient presenting with severe septic arthritis due to Ralstonia pickettii identified by molecular-based assays: a case report. Cases J 2: 8125, 2009. (pubmed)

 

098. S.P. Georgiadou and G.N. Dalekos. Which level of immunosuppression is harmful for occult hepatitis B virus infection?: ‘A million dollar’ answer.  Liver International (letter) 29: 1127-1128, 2009. (pdf)

 

097. Makaritsis KP, Gatselis NK, Ioannou M, Petinaki E, Dalekos GN. Polyclonal hypergammaglobulinaemia and high smooth muscle autoantibodies titres with specificity against filamentous actin: Think about visceral leishmaniasis, not only autoimmune

hepatitis. Int J Infect Dis 13: e157-60, 2009. (pubmed)

 

096. Sakkas LI, Davas EM, Kapsalaki E, Boulbou M, Makaritsis K, Alexiou I, Tsikrikas T, Stathakis N. Hematogenous spinal infection in central Greece. Spine (Phila Pa 1976) 2009; 34:E513-8. (pubmed)

 

095. S.P. Georgiadou, C. Liaskos, K. Zachou, S. Gabeta, E.I. Rigopoulou, and G.N. Dalekos. Occult hepatitis B virus infection in Greek patients with autoimmune liver diseases. Liver International 29: 434-42, 2009. (pubmed)

 

094. A. Stefos, N. Gatselis, K. Zachou, E. Rigopoulou, C. Hadjichristodoulou, and G.N. Dalekos. Descriptive epidemiology of chronic hepatitis B by using data from a hepatitis registry in central Greece. Eur J Intern Med 20: 35-43, 2009. (pubmed)

 

093. I. Goulis and G.N. Dalekos. Entecavir monotherapy for lamivudine-refractory chronic hepatitis B. Expert Rev Anti-Infect Ther 6:855-859, 2008. (Invited review). (pubmed)

 

092. S. Gabeta, G.L. Norman, C. Liaskos, N. Gatselis, P.A. Papamichalis, A. Garagounis, K. Zachou, E.I. Rigopoulou and G.N. Dalekos. IgA anti-b2GPI antibodies in patients with autoimmune liver diseases. J Clin Immunol 28: 501-11, 2008. (pubmed)

 

091. Stefanidis I, Giannopoulou M, Liakopoulos V, Dovas S, Karasavvidou F, Zachou K, Koukoulis GK, Dalekos GN. A case of membranous nephropathy associated with Sjogren syndrome, polymyositis and autoimmune hepatitis. Clin Nephrol 70: 245-50, 2008. (pubmed)

 

090. P. Fytili, G.N. Dalekos, M. Cornberg, V. Schlaphoff, W. Zauner, K. Zachou, M.P. Manns, C. Klade and H. Wedemeyer. Cross-genotype-reactivity of the immunodominant HCV-CD8 T-cell epitope NS3-1073: Significance for the development of peptide-based vaccines against HCV. Vaccine 26: 3818-26, 2008. (pubmed)

 

089. K. Kyriakopoulou, A. Antoniou, I.V. Fezoulidis, N.L. Kelekis, G.N. Dalekos, M. Vlychou. The role of Doppler Perfusion Index as screening test in the characterization of focal liver lesions. Dig Liver Dis 40: 755-60, 2008. (pubmed)

 

088. A. Tsikrikoni, E.I. Rigopoulou, K. Zachou, C. Liaskos, D. Kyriakou, and GN Dalekos. Bone marrow findings in patients with autoimmune liver diseases. J Gastroenterol Hepatol 23: e416-21, 2008. (pubmed)

 

087. D.P. Bogdanos and G.N. Dalekos. Enzymes as autoantigens of liver-specific autoimmunity. Curr Med Chem 15:2285-2292, 2008.(Invited review). (pubmed)

 

086. E.I. Rigopoulou and G.N. Dalekos. Molecular diagnostics of primary biliary cirrhosis. Expert Opinion on Medical Diagnostics 2: 621-634,2008. (Invited review).(pdf)

 

085. K. Zachou, P. Papamichalis, and G.N. Dalekos. Severe pharyngitis in stockbreeders: an unusual presentation of brucellosis. Occup Med 58:305-307, 2008. (pubmed)

 

084. G.N. Dalekos, D.P. Bogdanos and J. Neuberger. Celiac disease-related autoantibodies in end-stage autoimmune liver diseases: What is the message? Liver International 28:426-428, 2008. (Editorial). (pubmed)

 

083. Y. Renaudineau, G.N. Dalekos, P. Guéguen, K. Zachou, P. Youinou. Anti-α-actinin antibodies cross-react with anti-ssDNA antibodies in active autoimmune hepatitis. Clin Rev Allergy Immunol 34:321-325, 2008. (pubmed)

 

082. E. M. Hennes, M Zeniya, A. J. Czaja, A. Parés, G. N. Dalekos, E. Krawitt, P.L. Bittencourt, G. Porta, K.M. Boberg, H. Hofer, F.B. Bianchi, M Shibata, C. Schramm, B. Eisenmann de Torres, P. R. Galle, I. McFarlane, H. P. Dienes, A. W. Lohse. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48:169-176, 2008. (pubmed)

 

081. Davas EM, Alexiou I, Boulbou M, Koutroumpas A, Makaritsis K, Stathakis N, Sakkas LI. Co-morbidities increase the risk of serious infections in patients with rheumatoid arthritis treated with TNFalpha inhibitors. J Infect 2008; 57:418-20. (pubmed)

 

080. E.I. Rigopoulou and GN Dalekos. Autoimmune hepatitis: of host and pathogen. Hepatology (letter) 47:2147-2148, 2008. (pubmed)

 

079. TA Zografos, C Liaskos, EI Rigopoulou, E Togousidis, K Makaritsis, A Germenis, GN Dalekos. Adiponectin: a new independent predictor of liver steatosis and response to IFN-α treatment in chronic hepatitis C? Am J Gastroenterol 103:605-614, 2008. (pubmed)

 

078. Bogdanos DP, Rigopoulou EI. Viral/self-mimicry and immunological cross-reactivity as a trigger of hepatic C virus associated autoimmune diabetes. Diabetes Res Clin Pract 2007; 77:155-6. (pubmed)

 

077. Rigopoulou EI, Abbott WG, Williams R, Naoumov NV. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus. Antiviral Res 2007; 75:36-42. (pubmed)

 

076. E.I. Rigopoulou, ET Davies, DP Bogdanos, C Liaskos, M Mytilinaiou, GK Koukoulis, GN Dalekos, D Vergani. Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis. Liver Intern27:1226-1231, 2007. (pubmed)

 

075. PA Papamichalis, K Zachou, GK Koukoulis, A Veloni, EG Karacosta, L Kypri, I Mamaloudis, S Gabeta, EI Rigopoulou, AW Lohse, GN Dalekos. The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders. J Autoimmune Dis 4:3, 2007. (pubmed)

 

074. S. Gabeta, G.L. Norman, C. Liaskos, P.A. Papamichalis, T. Zografos, A. Garagounis, E.I. Rigopoulou and G.N. Dalekos. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis. J Clin Immunol 27:378-387, 2007. (pubmed)

 

073. DP Bogdanos, C Liaskos, A Pares, G Norman, EI Rigopoulou, L Caballeria, GN Dalekos, J Rodes, D Vergani. Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis. Hepatology (letter) 45:1583, 2007. (pubmed)

 

072. E.I. Rigopoulou, G. Dalekos, D.P. Bogdanos. How common are connective tissue disorders in patients with autoimmune hepatitis? Sem Arthritis Rheum (letter) 36:332, 2007. (pubmed)

 

071. E.I. Rigopoulou, D-P Bogdanos, C. Liaskos, A. Koutsoumpas, H. Baum, D. Vergani, and G.N. Dalekos. Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis. Clin Chim Acta 380:118-21, 2007. (pubmed)

 

070. N.K. Gatselis, K. Tepetes, A. Loukopoulos, K. Vasiou, A. Zafiriou, C. Gioti, and G.N. Dalekos. Hepatitis B virus and intrahepatic cholangiocarcinoma: report of two cases and review of the literature. Cancer Investigation 25:55-8, 2007. (pubmed)

 

069. A. Daponte, M. Ioannou, C. Gioti, A. Kallitsaris, G.N. Dalekos, I.E. Messinis. Primary retroperitoneal non-Hodgkin lymphoma presenting with torturous generalized pruritus in an elderly. Arch Gynecol Obstet 275:287-289, 2007. (pubmed)

 

068. N. Gatselis, A. Stefos,  C. Gioti, E. Rigopoulou, G.N. Dalekos. Primary biliary cirrhosis and Henoch-Schonlein purpura: Report of two cases and review of the literature. Liver Intern 27:280-283, 2007. (pubmed)

 

067. C. Liaskos, D.P. Bogdanos, E.I. Rigopoulou, G.N. Dalekos. Development of anti-mitochondrial antibodies in patients with autoimmune hepatitis: art of facts or an artifact? J Gastroenterol Hepatol (letter) 22:454-455, 2007. (pubmed)

 

066. E.I. Rigopoulou, M. Mytilinaiou, O. Romanidou, C. Liaskos, G.N. Dalekos. Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis. J Autoimmune Dis 4(1): 2, 2007. (pubmed)

 

065. N.K. Gatselis, E. Rigopoulou, A. Stefos, M. Kardasi, and G.N. Dalekos. Risk factors associated with HCV infection in semi-rural areas of central Greece. Eur J Intern Med 18:48-55, 2007. (pubmed)

 

064. Kouloubinis A, Kaklamanis L, Ziras N, Sofroniadou S, Makaritsis K, Adamopoulos S, Revela I, Athanasiou A, Mavroudis D, Georgoulias V. ProANP and NT-proBNP levels to prospectively assess cardiac function in breast cancer patients treated with cardiotoxic chemotherapy. Int J Cardiol 2007; 122:195-201. (pubmed)

 

063. C. Liaskos, D.P. Bogdanos, E.T. Davies, G.N. Dalekos. Diagnostic relevance of anti-filamentous actin antibodies in autoimmune hepatitis. J Clin Pathol (Letter) J Clin Pathol (Letter) 60:107-108, 2007. (pubmed)

 

062. M. Satra, N. Gatselis, D. Iliopoulos, D. Zacharoulis, G.N. Dalekos, A. Tsezou. Real time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis. J Viral Hepat 14:41-7, 2007.(pubmed)

 

061. N.K. Gatselis, S.P. Georgiadou, G.K. Koukoulis, N.Tassopoulos, K. Zachou, C. Liaskos, A. Hatzakis, G.N. Dalekos. Clinical significance of organ and non-organ specific autoantibodies on the response to antiviral treatment of patients with chronic hepatitis C.Aliment Pharmacol Ther 24:1563-1573, 2006. (pubmed)

 

060. P. Guéguen, G. Dalekos, J-B Nousbaum, K. Zachou, Putterman C, Youinou P, Renaudineau Y. Double reactivity against actin and α-actinin defines a severe form of autoimmune hepatitis type 1. J Clin Immunol 26: 495-505, 2006. (pubmed)

 

059. Bogdanos DP, Rigopoulou EI. Self-mimicking autoimmune domains of hepatitis C virus core antigen. Vaccine 2006; 24:6173-4. (pubmed)

 

058. Makaritsis KP, Liakopoulos V, Leivaditis K, Eleftheriadis T, Stefanidis I. Adaptation of renal function in heart failure. Ren Fail2006;28:527-35. (pubmed)

 

057. G.N. Dalekos, K. Makaritsis, E.I. Rigopoulou. Redesigning training for internal medicine. What needs to be done? Ann Intern Med (Letter) 145:865, 2006.(pubmed)

 

056. E. Tsironi, N. Gatselis, M.G. Kotoula, D.Z. Chatzoulis and G.N. Dalekos. Unexplained choroidal embolization: Remember the antiphospholipid syndrome Lancet 368:1936, 2006. (pubmed)

 

055. A.I. Papaioannou, K. Kostikas, N. Tzovaras, T.S. Kiropoulos, A. Loukopoulos, M.G. Ioannou, F. Karasavvidou, G.N. Dalekos, K.I. Gourgoulianis. Mantle Cell Lymphoma Presenting With Persistent Pleural Effusion and Severe Thrombocytopenia. The Internet Journal of Pulmonary Medicine 6: 2, 2006.

 

054. E.Petinaki and G.N. Dalekos. Molecular methods as tools for the diagnosis of bacterial infections: useful or useless? Res Adv Microbiology 6:23-31, 2006. (Invited review).

 

053. N. Stefanou, M. Satra, V. Papanikolaou, F. Kalala, N. Gatselis, A. Germenis, G.N. Dalekos, A. Tsezou. Leptin receptor isoforms mRNA expression in peripheral blood mononuclear cells from patients with chronic viral hepatitis. Exp Biol Med 231:1653-1663, 2006. (pubmed)

 

052. K. Mimidis, V.P Papadopoulos, I. Elefsiniotis, D. Koliouskas, I. Ketikoglou, E. Paraskevas, S. Kanatakis, D. Chrysagis, G.N Dalekos, C. Tzathas, A. Protopapas, E. Gigi, E. Tsianos, G. Kartalis. Hepatitis C virus survival curve analysis in naïve patients treated with peg-interferon a-2b plus ribavirin. A randomized controlled trial for induction with high doses of peg-interferon and predictability of sustained viral response from early virologic data. J Gastrointestin Liver Dis 15: 213-219, 2006. (pubmed)

 

051. D.P. Bogdanos, C. Liaskos, E.I. Rigopoulou, G.N. Dalekos. Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen. Clin Chim Acta (Letter) 373:183-184, 2006. (pubmed)

 

050. E.I. Rigopoulou, S.P. Georgiadou, S. Barbanis, G.N. Dalekos. Lack of association between appendectomy and primary biliary cirrhosis (PBC). Scand J Gastroenterol 41:573-576, 2006. (pubmed)

 

049. K. Zachou, C. Liaskos, E. Rigopoulou, S. Gabeta, P. Papamichalis, N. Gatselis, S. Georgiadou, and G.N. Dalekos. Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. Clin Immunol 119:203-212, 2006. (pubmed)

 

048. T.A. Zografos, E.I. Rigopoulou, C. Liaskos, E. Togousidis, K. Zachou, N. Gatselis, A. Germenis and G. N. Dalekos. Alterations of leptin during IFN-a therapy in patients with chronic viral hepatitis. J Hepatol 44:848-55, 2006. (pubmed)

 

047. H. L. Tillmann, J. Hadem, L. Leifeld, K. Zachou, A. Canbay, C. Eisenbach, I. Graziadei, J. Encke, H. Schmidt, W. Vogel, A. Schneider, U. Spengler, G. Gerken, G.N. Dalekos, H. Wedemeyer, M. P. Manns. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat 13:256-63, 2006.  (pubmed)

 

046. N. Tzovaras, A. Stefos, S.P. Georgiadou, N. Gatselis, G. Papadamou, E. Rigopoulou, M. Ioannou, I. Skoularigis and G.N. Dalekos. Reversion of severe hepatopulmonary syndrome in a non-cirrhotic patient after corticosteroid treatment for granulomatous hepatitis: A case report and review of the literature. World J Gastroenterol 12:336-339, 2006. (pubmed)

 

045. N. Gatselis, E. Malli, G. Papadamou, E. Petinaki, and G.N. Dalekos. Direct detection of Cardiobacterium hominis in serum from a patient with infective endocarditis by broad-range bacterial PCR. J Clin Microbiol 44:669-672, 2006. (pubmed)

 

044. I. Nikaina, C. Pastaka, K. Zachou, G.N. Dalekos, K. Gourgoulianis. Sleep apnoea syndrome and early stage cirrhosis: a pilot study. Eur J Gastroenterol Hepatol 18:31-35, 2006. (pubmed)

 

043. I. Stefanidis, V. Liakopoulos, E.I. Rigopoulou, G.N. Dalekos. Diagnostic discordance for hepatitis C virus infection in hemodialysis: correlations with clinical and laboratory features. Am J Kidney Dis (Letter) 46:992-993, 2005. (pubmed)

 

042. K.Zachou, E. Rigopoulou, A. Tsikrikoni, M. Alexandrakis, F. Passam, D. Kyriakou, N. Stathakis and G.N. Dalekos. Cytokines production is distinct in bone marrow cultures from patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. J Autoimmun 25:283-288, 2005. (pubmed)

 

041. A.E. Germenis, E.E. Yiannaki, K. Zachou, V. Roka, S. Barbanis, C. Liaskos, K. Adam, A.N. Kapsoritakis, S. Potamianos, G.N. Dalekos. Prevalence and clinical significance of IgA antibodies against tissue transglutaminase in patients with diverse chronic liver diseases. Clin Diag Lab Immunol 12:941-948, 2005. (pubmed)

 

040. E.I. Rigopoulou, I. Stefanidis, C. Liaskos, E.K. Zervou, C. Rizos, P. Mina, K. Zachou, C. Syrganis, E. Patsidis, G. Kyriakopoulos, L. Sdrakas, N. Tsianas and G.N. Dalekos. HCV RNA qualitative assay based on transcription mediated amplification improves the efficacy of detection of HCV infection of patients on haemodialysis: results from five haemodialysis units in central Greece. J Clin Virol 34:81-85, 2005. (pubmed)

 

039. E.K. Zervou, N.K. Gatselis, E. Xanthi, K. Ziciadis, S.P. Georgiadou, and G.N. Dalekos. Intrafamilial spread of hepatitis B virus infection in Greece. Eur J Gastroenterol Hepatol 17:911-915, 2005. (pubmed)

 

038. E.K. Zervou, S.P. Georgiadou, G.K. Liapi, F. Karabini, V. Giogiakas, K. Zisiadis, N.K. Gatselis, I. Goudevenos and G.N. Dalekos. Hepatitis viruses and human T-lymphotropic virus type I/II infection markers in patients underwent an open-heart surgery: Evidence of increased risk for exposure to HBV and HEV. Eur J Intern Med 16:424-428, 2005. (pubmed)

 

037. M. Satra, G.N. Dalekos, P. Kollia, N. Vamvakopoulos, A. Tsezou. Telomerase reverse transcriptase mRNA expression in peripheral lymphocytes of patients with chronic HBV and HCV infections. J Viral Hepat 12:488-493, 2005. (pubmed)

 

036. A. Stefos, S.P. Georgiadou, C. Gioti, A. Loukopoulos, M. Ioannou, S. Pournaras, and G.N. Dalekos. Leptospirosis and pancytopenia: Two case reports and review of the literature. J Infection 51:e277-280, 2005. (pubmed)

 

035. C. Liaskos, E. Rigopoulou, K. Zachou, S. Georgiadou, N. Gatselis, and G.N. Dalekos. Prevalence and clinical significance of anticardiolipin antibodies in patients with autoimmune hepatitis type 1. J Autoimmun 24:251-260, 2005. (pubmed)

 

034. E.I. Rigopoulou, E.T. Davies, A. Pares, K. Zachou, C. Liaskos, D.P. Bogdanos, J. Rodes, G.N. Dalekos, D. Vergani. Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut 54:528-532, 2005. (pubmed)

 

033. A. Tsikrikoni, D.S. Kyriakou, E.I. Rigopoulou, M.G. Alexandrakis, K. Zachou, F. Passam, and G.N. Dalekos. Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. J Hepatol 42:393-399, 2005. (pubmed)

 

032. Ν.Κ. Gatselis, S.P. Georgiadou, N. Tassopoulos, K. Zachou, C. Liaskos, A. Hatzakis, and G.N. Dalekos. Impact of parietal cell autoantibodies (PCA) and non-organ specific autoantibodies (NOSA) on the tratment outcome of patients with HCV infection: a pilot study. World J Gastroenterol 11:482-487, 2005. (pubmed)

 

031. E.K. Zervou, S. Georgiadou, M. Tzilianos, P. Georgitsi, V. Pournara, S. Nousis, C. Pappas, L. Daskalou, A. Vrettou, F. Karabini, and G.N. Dalekos. Human T-lymphotropic virus type-I/II infections in volunteer blood donors of north and west Greece. Eur J Intern Med 15:422-427, 2004. (pubmed)

 

030. I. Stefanidis, E.K. Zervou, Ch. Rizos, Ch. Syrganis, E. Patsidis, G. Kyriakopoulos, L. Sdrakas, N. Tsianas, Rigopoulou EI, Liakopoulos V, G.N. Dalekos. Hepatitis E virus antibodies in hemodialysis patients: an epidemiological survey in central Greece. Int J Artif Organs 27:842-847, 2004. (pubmed)

 

029. E. E. Yiannaki, E. Zintzaras, A. Analatos, C. Theodoridou, G.N. Dalekos, A.E. Germenis. Evaluation of a microsphere-based flow cytometric assay for diagnosis of celiac disease. J Immunoassay Immunochem 25:345-357, 2004. (pubmed)

 

028. K. Zachou, E. Rigopoulou, and G.N. Dalekos. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J Autoim Dis 1:2, 2004 (15 October 2004) (Invited Review; this article has qualified as ‘Highly accessed’; Accesses 5296 up to 3-01-2006). (pubmed)

 

027. A.N. Moulas, A. Noulas, E. Makri, G. Papadamou, S. Bonanou-Tzedaki, G.N. Dalekos. Total antioxidant status and erythrocyte superoxide dismutase activity in patients with chronic hepatitis B and C. Eur J Inflam 2:77-84, 2004.

 

026. E. Rigopoulou, G.N. Dalekos. Anti-sp100 antibodies in primary biliary cirrhosis. Scand J Gastroenterol (Letter) 39:406-407, 2004.(pubmed)

 

025. S.P. Georgiadou, K. Zachou, C. Liaskos, E. Rigopoulou, P.Mina, F. Gerovasilis, E. Makri, G.N. Dalekos. Occult hepatitis B virus (HBV) infection in Greek patients with chronic hepatitis C and diverse non-viral hepatic diseases. J Viral Hepat 11:358-365, 2004. (pubmed)

 

024. N. Kelekis, E. Makri, A. Vasiou, K. Patsiaoura, M. Spiridakis and G.N. Dalekos. Confluent hepatic fibrosis as the presenting imaging sign in non-advanced alcoholic cirrhosis. Clin Imaging 28:124-127, 2004. (pubmed)

 

023. K. Zachou, E. Rigopoulou, C. Liaskos, K. Patsiaoura, E. Makri, N. Stathakis, G.N. Dalekos. Primary biliary cirrhosis presented as peripheral eosinophilia in asymptomatic women with or without elevated alkaline phosphatase. Eur J Gastroenterol Hepatol 16:425-428,2004. (pubmed)

 

022. G.N. Dalekos, P. Obermayer-Straub, M. Bartels, T. Maeda, A. Kayser, S. Loges, S. Braun, E. Schmidt, M.E. Gershwin, M.P. Manns. Cytochrome P450 2A6: A new hepatic autoantigen in chronic hepatitis C virus infection. J Hepatol 39:800-806, 2003. (Original article with Editorial). (pubmed)

 

021. D.S. Kyriakou, M.G. Alexandrakis, K. Zachou, F. Passam, N.E. Stathakis and G.N. Dalekos. Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1 and primary billiary cirrhosis. J Hepatol 39:679-685, 2003. (pubmed)

 

020. A. Polyzos, C. Sinani, N. Kelekis, G. Papadamou, K. Patsiaoura, G.N. Dalekos. Advanced-stage intrahepatic cholangiocarcinoma in a patient with end-stage HCV-associated liver disease. Eur J Gastroenterol Hepatol 15:331-334, 2003. (pubmed)

 

019. E. Zervou, D.S. Boumba, Ch. Liaskos, S. Georgiadou, E.V. Tsianos, and G.N. Dalekos. Low prevalence of HCV, HIV and HTLV-I/II infection markers in northwestern Greece: Results of a three year prospective donor study. Eur J Intern Med 14:39-44, 2003. (pubmed)

 

018. K. Zachou, C. Liaskos, D.K. Christodoulou, M. Kardasi, G. Papadamou, N. Gatselis, S.P. Georgiadou, E.V. Tsianos, and G.N. Dalekos. Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I co-factor or features of antiphospholipid syndrome.  Eur J Clin Invest 33:161-168, 2003. (pubmed)

 

017. G.N. Dalekos, K. Zachou, C. Liaskos, N. Gatselis. Autoantibodies and defined target-autoantigens in autoimmune hepatitis: An overview. Eur J Intern Med 13:293-303, 2002. (pubmed)

 

016. G.N. Dalekos, E. Makri, S. Loges, P. Obermayer-Straub, K. Zachou, Th. Tsikrikas, G. Papadamou, M.P. Manns. Increased incidence of anti-LKM autoantibodies in a consecutive cohort of HCV patients from central Greece. Eur J Gastroenterol Hepatol 14:35-42, 2002. (pubmed)

 

015. P. Obermayer-Straub, J. Perheentupa, S. Braun, A. Kayser, A. Barut, S. Loges, A. Harms, G. Dalekos, C.P. Strassburg, M.P. Manns. Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Gastroenterology 121:668-677, 2001. (pubmed)

 

14. D.K. Christodoulou, G.N. Dalekos, M. Merkouropoulos, K.G. Kistis, G. Georgitsi, E. Zervou, K. Zachou, E.V. Tsianos. Cryoglobulinemia due to chronic viral hepatitis infections is not a major problem in clinical practice. Eur J Intern Med, 12: 435-441, 2001 (pubmed)

 

013. G.N. Dalekos, K. Zachou, Ch. Liaskos. The antiphospholipid syndrome and infection. Curr Rheumatol Reports, 3: 277-285, 2001. (Invited review). (pubmed)

 

012. E.K. Zervou, G.N. Dalekos, D.S. Boumba, E.V. Tsianos. Value of anti-HBc screening of blood donors for prevention of HBV infection: Results of a three year prospective study in northwestern Greece. Transfusion, 41: 652-658, 2001. (pubmed)

 

011. G.N. Dalekos, E. Galanakis, E. Zervou, M. Tzoufi, P.L. Lapatsanis, E.V. Tsianos. Interferon-alpha treatment of children with chronic hepatitis D virus infection: The Greek experience. Hepato-Gastroenterology, 47: 1072-1076, 2000. (pubmed)

 

010. G.N. Dalekos, K. Kistis, D. Boumba, E. Zervou, P. Voulgari, A.A. Drosos, E.V. Tsianos. Increased incidence of anticardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to antiphospholipid syndrome. Eur J Gastroenterol Hepatol 12: 67-74, 2000. (pubmed)

 

009. M. Fatouros, G.N. Dalekos, E. Mylonakis, G. Vekinis, A. Kapas. Alterations in body weight, breaking strength and wound healing in Wistar rats treated pre- and postoperatively with erythropoietin or granulocyte-macrophage colony stimulating factor: Evidence of a previously unknown anabolic effect of erythropoietin? J Lab Clin Med 133: 253-259, 1999. (pubmed)

 

008. G.N. Dalekos, H. Wedemeyer, P. Obermayer-Straub, A. Kayser, A. Barut, H. Frank, M.P. Manns. Epitope mapping of cytochrome P450 2D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment. J Hepatol 30: 366-375, 1999. (pubmed)

 

007. G.N. Dalekos, E. Zervou, M. Elisaf, D.S. Boumba, K. Katopodis, G. Sferopoulos, K.C. Siamopoulos, E.V. Tsianos. Increased prevalence of markers of GBV-C/HGV infection in a selected cohort of haemodialysis patients negative for other blood-borne viruses.Nephrol Dial Transpl (Letter), 14: 255-256, 1999. (pubmed)

 

006. G.N. Dalekos, D. Christodoulou, K. G. Kistis, J. Hatzis, E.V. Tsianos. A prospective evaluation of dermatologic side effects during interferon-alpha therapy for chronic viral hepatitis. Eur J Gastoenterol Hepatol 10:933-939, 1998. (pubmed)

 

005. G.N. Dalekos, K. Achenbach, D. Christodoulou, G.K. Liapi, E. Zervou, D. Sideris, E.V. Tsianos. Idiopathic dilated cardiomyopathy: lack of association with hepatitis C virus infection. Heart 80: 270-275, 1998. (pubmed)

 

004. K.L. Bourantas, G.N. Dalekos, A. Makis, A. Chaidos, S. Tsiara, A. Mavridis. Acute phase proteins and interleukins in steady state sickle cell disease. Eur J Haematol 61: 49-54, 1998. (pubmed)

 

003. G.N. Dalekos, D.S. Boumba, K. Katopodis, E. Zervou, G. Sferopoulos, M. Elisaf, E.V. Tsianos, K.C. Siamopoulos. Absence of viraemia due to HCV in anti-HCV negative haemodialysis patients. Nephrol Dial Transpl 13: 1804-1806, 1998. (pubmed)

 

002. G.N. Dalekos, E. Zervou, M. Elisaf, N. Germanos, K. Bourantas, E. Galanakis, K.C. Siamopoulos, E.V. Tsianos. Antibodies to hepatitis E virus among different populations in Greece: increased prevalence in an haemodialysis unit. Transfusion 38: 595-598, 1998. (pubmed)

 

001. G.N. Dalekos, J. Ringstad, I. Savaidis, K.I. Seferiadis, E.V. Tsianos. Zinc, copper and immunologic markers in the circulation of well nourished patients with ulcerative colitis. Eur J Gastoenterol Hepatol 10:331-337, 1998. (pubmed)